New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister's visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19.
'Novotech is a fantastic success story demonstrating the global value of NSW's strengths in life sciences and clinical trials,' said Minister Chanthivong. 'I was thrilled to learn about Novotech's growth in the Republic of Korea and the central role their business plays in bringing Korean biotech innovation to the world. Investment NSW looks forward to continuing to support Novotech as it generates export dollars for our state while helping people around the world tackle serious health issues.'
Minister Chanthivong was joined by a delegation including: Brooke O'Rourke, Chief of Staff to Minister Chanthivong.
Rebecca McPhee, Deputy Secretary of Investment NSW.
David Lawson, NSW Trade & Investment Commissioner for Japan & Korea.
Yoojin Kim, NSW Trade & Investment Director for Korea.
The delegation engaged with Novotech leaders Dr. Yooni Kim, Hyun Kim, and Lilian Kim, who shared insights into Novotech's growth as a global clinical research organization and the expanding role of South Korea as a premier destination for clinical trials.
'We are honored that the Australian NSW Trade Minister and senior officials from NSW Investment have selected Novotech as a leading example of collaboration between Australia and South Korea,' said Dr. Yooni Kim, Managing Director – Asia-Pacific at Novotech. 'This visit reinforces the strong and growing partnership between the two countries in the clinical research and biopharmaceutical sector. As the largest Australian-founded global services company operating in South Korea, Novotech is committed to creating more success stories that demonstrate the value of this collaboration. I believe Novotech's strong partnership with the Australian NSW government and their NSW Investment can mutually benefit Korean biotech companies and the Australian clinical trial market.'
The discussion reinforced Novotech's strong partnership with Australia, supported by a track record of successful clinical trials and a shared vision for future innovation. With increasing interest from Korean biotechs to conduct research in Australia, both parties explored opportunities to enhance bilateral cooperation and accelerate cross-border clinical development.
Novotech, recently recognized as the Best CRO in Australia by IMAPAC's Asia-Pacific Biopharma Excellence Awards, continues to solidify its position as the region's leading clinical development partner. The company offers Korean biotech sponsors seamless access to Australia's world-class research infrastructure, regulatory expertise, and accelerated clinical pathways. Through its integrated full-service model, Novotech enables Korean biotechs to confidently expand early-phase programs into Australia, backed by deep regional knowledge and globally aligned operational standards.
About Novotech Novotech-CRO.com
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase.
With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations.
Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide.
Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies.
Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results
For more information or to speak to an expert team member visit www.Novotech-CRO.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250527294947/en/
Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
an hour ago
- Los Angeles Times
H Mart opens to long lines, hungry customers in Westminster
A few red pop-up tents outside the new H Mart supermarket in Westminster provided some shade to the many customers who braved the 90-degree heat for its grand opening on a recent Thursday. Under the tents, members of the Korean grocer's rewards program were offered free tote bags and other gifts, items such as chopsticks, floral bowls and vegetable strainers. Nearby, the line to get into the H Mart stretched well beyond the neighboring Daiso Japanese Household Goods store. Located at 16450 Beach Blvd., H Mart Westminster is the company's 19th store in California and the sixth in Orange County. At 72,916 square feet, it is also the chain's largest location. The opening on Aug. 7 featured a traditional lion dance for good luck and comments from local officials, including Assemblyman Tri Ta, Westminster Mayor Chi Charlie Nguyen and James Bong Cho, president of the Korean American Federation of Orange County. 'Westminster is a culturally diverse community, and we are excited to welcome H Mart into our city,' Nguyen said. 'As the largest Asian American supermarket chain in the United States, H Mart's products and offerings will resonate well with our residents and visitors alike.' H Mart opened its first store in Woodside, Queens, N.Y. in 1982 and has since grown into a national supermarket chain with more than 100 locations in 18 states. Its stores stock a wide assortment of Asian groceries, from fresh produce, meats, seafood and pantry staples to frozen foods, health and beauty products and appliances. The grocery store is a one-stop shop for many Korean American households looking for special treats or specific ingredients, like Napa cabbage to make kimchi. Customers swarmed to the new store for items like viral fruit-shaped ice cream, RNR Korean chestnut bread and doorbuster sales like a 15-pound bag of Haru Haru rice for a $1 with a $200 purchase. The store has an expanded cooking appliances and home goods area, with Sanrio merchandise, dishes, rice cookers and electric griddles. Another big draw for the store is a food hall that provides 11 dining options. Brian Kwon, H Mart's president, said the food hall will make H Mart Westminster a destination for local community members who are looking to Asian grocery stores to not only provide culturally specific ingredients and products, but experiences, too. 'H Mart is excited to bring an authentic taste of Asia to your neighborhood and we hope our customers share in our enthusiasm,' Kwon said in a statement. 'Our market is all about celebrating the richness and variety of Asian cuisine, making it easier than ever to find the flavors you love, right here at home.' The food hall is home to Moobongri Soondae Express, which serves authentic Korean blood sausage, soups and stews; Paik's Noodle, known for Korean-style Chinese food; and Chang Hwa Dang, which serves Korean dumplings. KZ Mori serves Japanese fusion cuisine while Yoo's Place and Goobne Chicken offer Korean street food options and Eggcellent features egg sandwiches and coffee. The food hall also houses two Korean concepts that found fame through mukbang videos; Jaws Topokki, which specializes in tteokbokki (also called topokki), a spicy braised rice cake soup, and Myungrang Hot Dog, which serves Korean-style corn dogs. Both concepts were previously only found locally at the Source in Buena Park, a culture-defining hub for Orange County's Koreatown. Other recognizable brands include the popular French Asian bakery chain, Tous Les Jours and the Taiwanese bubble tea concept, Gong Cha. Three of the other five H Marts in Orange County are located in the city of Irvine. The chain's newest location sits near the Huntington Beach border, in proximity to Little Saigon and the large Asian American communities found in Fountain Valley, Garden Grove and Buena Park. Orange County has an appetite for Asian grocery stores, as the county also welcomed its third Toyko Central store at Heritage Plaza shopping center in Irvine just a couple of weeks ago and anticipates the first SoCal T&T Supermarket, Canada's largest Asian grocery chain, to open in Irvine in 2026. 'It is nice to have [an H Mart] closer to where we are so we don't to go all the way to Garden Grove or Irvine,' said Arthur Nguyen, a Fountain Valley resident who shopped with his girlfriend on the store's opening day. H Mart Westminster is located at 16450 Beach Blvd. and is open daily from 8 a.m. to 10 p.m.
UPI
an hour ago
- UPI
Google, Apple lose 'Fortnite' anticompetition lawsuit in Australia
On Tuesday, an Australian judge ruled that Google and Apple's dominance over the in-store app marketplace was anticompetitive. Epic Games called it a "win" for Australian developers and consumers as the popular games Fortnite is set to return to iOS platforms in Australia. Photo by Keizo Mori/UPI | License Photo Aug. 12 (UPI) -- Epic Games said its popular Fortnite video game will return to iOS platforms in Australia after its high court ruled on Tuesday that Google and Apple's dominance over the digital marketplace was anticompetitive. Australian federal Judge Jonathan Beach ruled that both Google and Apple had misused their positions as the dominant players over in-app purchase commissions that included fees of up to 30% to cut back on competition. On Tuesday, CEO Tim Sweeney said Fortnite will return to iPhones along with its Epic Games Store "at a date to be determined." In a social media post, Sweeney called the ruling a "victory" in Australian antitrust proceedings via its nearly five-year-long legal battle against the tech giants. Apple, the judge said, engaged in conduct that had the purpose or was "likely to have or had the effect of substantially lessening competition in such markets." He added that Google's conduct "had or is likely to have had the effect of substantially lessening competition in such markets." Beach pointed to Apple's specific conduct that "prevents prohibits the direct downloading or sideloading of native apps and conduct that prevents or prohibits developers and users from using alternative payment methods." But he rejected the accusations by Epic that the two companies had otherwise violated consumer laws and exhibited "unconscionable conduct." Epic added that officials still need to sift through the nearly 2,000 pages of legal documents stemming from Tuesday's ruling. Both Google and Apple officials "welcomed" Beach's rejection of certain parts of the ruling, but disagreed with the other aspects of Epic's characterizations and court victory. Google spokesperson Dan Jackson said it disagreed with the "court's characterization of our billing policies and practices." He added it included "findings regarding some of our historical partnerships, which were all shaped in a fiercely competitive mobile landscape on behalf of users and developers," he told The Verge. "We will review the full decision when we receive it and assess our next steps," Jackson said. The legal battle began in 2020 when Apple and Google kicked Fortnite off its app stores for bypassing their payment systems with its own. Legal action against Apple that year was followed by a 2021 lawsuit against Google Australia. Epic has filed lawsuits against both Apple and Google around the world in courts in Britain over in Europe and the United States. The California-based U.S. Ninth Circuit Court of Appeals in July upheld a 2023 jury verdict against Google, saying it violated state and federal antitrust law by holding an illegal monopoly in Android app distribution and billing, and that Google unlawfully tied its billing system to Play Store. On Tuesday, Apple officials stated the global tech giant faced "fierce competition in every market" where it operates. "We continuously invest and innovate to make the App Store the safest place for users to get apps and a great business opportunity for developers in Australia and around the world," Apple told ABC in Australia.
New York Post
2 hours ago
- New York Post
medicube's ‘Botox in a bottle' is half the price and worth every penny
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. I've spent years immersed in Korean skincare, practicing a meticulous ritual of testing beauty products from A to Z, from cult-favorite essences to up-and-coming niche serums. I've become something of a veteran evaluator in this field, having swatched, layered and geeked out over thousands of elixirs, creams and drops. So, it's in this context that I encountered the medicube Zero Exosome Shot, and let me tell you, the Amazon listing's current markdown — $20 with a 49% discount off its $39 list price — caught me immediately. It felt like the kind of rare, serendipitous moment within the beauty-buying world: a high-tech skincare innovation on sale, ripe for serious scrutiny. Not to mention, I reviewed the lion's share of medicube and I can say that it's one of the most efficacy-driven brand in the biz. Its stuff works. Advertisement At first glance, the packaging promises a transformative experience: 'Exosome‑Coated Technology,' micro‑needle‑like spicules packed with patented exosomes that deliver actives right into the pores, offering 'superior absorption' and 'hydration enhanced by 242%.' That claim alone sets a high bar in the world of liquid boosters. To unpack what's going on in that tiny amber vial (and why a sale feels like the perfect prompt to explore it), I looked closely at the ingredient roster. Let's ground ourselves in the chemistry before falling in love with the hype. Amazon The formula starts with hydrating humectants: water, followed by dipropylene glycol, butylene glycol and glycerin, ingredients that lay a solid foundation by drawing moisture into the skin. Then there's niacinamide, a renowned multitasker known to refine pores, even tone and strengthen the barrier that's reliable and mildly brightening. Panthenol (also known as pro‑vitamin B5) pairs with it, lending hydration and soothing anti‑inflammatory support. Before and after using the medicube One Day Exosome Shot 2000. Victoria Giardina The star players, however, are the hydrolyzed sponge (i.e., spicule) and lactobacillus extracellular vesicles — in other words, probiotic-derived exosomes. These microscopic 'shots' embed in the skin to create micro-channels, skillfully enhancing absorption while mimicking the effects of micro-needling, without breaking the skin barrier. The listing claims that these spicules penetrate pores to deliver the active ingredients, then 'naturally shed' over the following days, offering a gentle, rolling exfoliation and improved texture. It's one of the most satisfying skincare products in my routine. Complementing that duo, the serum includes AHA/BHA/PHA‑type acids, specifically shoring up exfoliation with betaine salicylate (a gentler oil‑soluble BHA) and gluconolactone (a PHA that exfoliates while being hydrating). Together, they support cellular turnover while remaining more skin‑friendly than conventional acids. Citric Acid helps adjust pH, enhancing efficacy and various botanical extracts. When used, your skin will drink up the antioxidant and soothing benefits. Let's consider how all this translates into application and effect, through the lens of someone like me who has collectively logged thousands of product experiences. This is marketed as a tingling ampoule; indeed, there is a somewhat needlelike sensation — like micro‑needling in a bottle. It is exactly that refined efficacy that appeals to those of us who are skincare minimalists but refuse to sacrifice performance. The timing of this Amazon sale makes the serum feel even more accessible. The price is suddenly not just tempting but reasonable for the kind of targeted exfoliation and enzyme‑like smoothing you're paying for. If you have sensitive skin, it's worth noting that the listing underscores that this serum is noncomedogenic, low‑irritating, gluten‑free, color‑free and safe for most skin types. Still, as always with treatments this potent — and especially one with micro‑spicules — patch testing is a must. What does this mean for the seasoned Korean skincare connoisseur, or the curious newcomer? In practice, as part of a nighttime routine, a gentle double cleanse, followed by this ampoule, then a calming hydrating layer and a nourishing emollient (or even overnight mask), creates a visible lift in texture and luminosity. With this, I instantly notice glass‑skin smoothness, visibly reduced pore volume and a plumper, more even canvas. These effects are highly coveted and impressive for a less-than-$50 product. The Final Verdict In short, having navigated hundreds of bottles promising refined pores and glow, I've learned to spot which claims are grounded in novel tech and which are simply rehashed marketing. The medicube Zero Exosome Shot leans firmly into innovation, exfoliation and value. And, this sale on Amazon tilts what might have been a luxury into a rational decision. Especially for those already performing diligent nightly rituals, this ampoule can amplify results in measurable, visible ways. If you're looking to elevate your routine with a gentle yet high-impact booster — especially now that it's on sale — it's precisely the kind of worth-it pick that Amazon is blessing us with.
